Search
Now showing items 11-20 of 20
Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
(Brac University, 2022-04)
A decade has passed since no new Alzheimer's disease (AD) therapies were approved, even
though it is the leading motive of dementia in the modern era. The community of patients with
AD leads to expansion. Anxiety, anger, ...
Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
(Brac University, 2022-04)
Purpose: Alzheimer's disease (AD) is a multifactorial neurodegenerative brain disorder that affects approximately 5.3 million people in the United States, including nearly half of the population aged 85 and up. It has ...
Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
(Brac University, 2022-11)
In neurology, Alzheimer's disease represents greatest unmet medical need. Formation of
neurofibrillary tangles, Amyloid Beta-peptide (Aβ) deposition, and significant oxidative
stress, synapse loss are features of the ...
Mini-mental state examination in hospitalized post COVID-19 patient to identify the risk of AlzheiMer`s development
(Brac University, 2023-02)
SARS Covid-19 has affected 6 million people in 2020 to 2022. The primary difficulty the patient faces respiratory difficulty. But the virus affects several peripheral systems as well. Central nervous system is one of the ...
A pharmacovigilance study of gender differences in rhabdomyolysis risk among donepezil users with alzheimer`s disease
(Brac University, 2023-10)
Alzheimer’s disease is the most common disease for older patients marked by symptoms of dementia. This study was conducted for the pharmacovigilance investigation of donepezil related to adverse event rhabdomyolysis among ...
Potential treatments for epigenetic dysregulation in neurological diseases
(Brac University, 2023-02)
Epigenetics is of great importance to modern neuroscience because of its link to the etiology of certain neurodegenerative diseases. The roles of epigenetic changes like DNA methylation and histone acetylation in transcriptional ...
Investigating the link between Cardiovascular diseases and neurodegenerative disorders
(Brac University, 2022-11)
Neurodegenerative (ND) disturbances (such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and spinal cord injury) are a notable public health concern across the world, and they are growing more ...
Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
(Brac University, 2023-02)
Alzheimer's disease (AD) is a progressive neurological condition marked by memory or cognitive impairment, behavioral changes, visuospatial difficulties, decreased propensity to carry out day to day living tasks, and ...
A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
(Brac University, 2023-02)
Alzheimer's Disease (AD) is a complex and common neurological disorder and dementia's leading cause. Memantine works to treat moderate to severe AD. This study focused on Food and Drug Administration Adverse Event Reporting ...
Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
(Brac University, 2023-02)
Galantamine is one of the common acetylcholinesterase inhibitors used to treat Alzheimer's
disease, a neurodegenerative disorder. This study was conducted to determine the impact of
galantamine on mortality rate and ...